These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3261818)

  • 21. Characterization of the antitumor activity of a polyantigenic immunomodulator (PAI): I--Utilization of cimetidine and cyclosporine A.
    Ríos-Olivares E; Orraca ZM; Carrasco-Canales JA; Alvarado L; Marchand AM; Colón JI
    Bol Asoc Med P R; 1989 Jul; 81(7):246-53. PubMed ID: 2789052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the accessory function of murine macrophages in vitro by cyclosporine.
    Manca F; Kunkl A; Celada F
    Transplantation; 1985 Jun; 39(6):644-9. PubMed ID: 3873733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplantation; 1991 Apr; 51(4):851-7. PubMed ID: 2014542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine blocks interleukin 2 (IL-2) gene expression and regulates IL-2 receptor expression.
    Rezai AR; Salazar-Gonzalez JF; Martínez-Maza O; Bramhall J; Afrasiabi R; Kermani-Arab V
    Immunopharmacol Immunotoxicol; 1990; 12(3):345-62. PubMed ID: 2266228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of radiation on the production of interleukins and T-lymphocyte activities.
    Manori I; Kushelevsky A; Segal S; Weinstein Y
    J Natl Cancer Inst; 1985 Jun; 74(6):1215-21. PubMed ID: 3923245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites.
    Fujiwara M; Mitsui K; Yamamoto I
    Jpn J Pharmacol; 1990 Oct; 54(2):121-31. PubMed ID: 1981793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of cimetidine and PSK on interleukin-2 production by PBL in patients with advanced ovarian carcinoma during the course of chemotherapy].
    Kikuchi Y; Kizawa I; Oomori K; Iwano I; Kita T; Miyauchi M; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1987-92. PubMed ID: 3501452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 2 and concanavalin A stimulate interferon-gamma production in a murine cytolytic T cell clone by different pathways.
    Dunn DE; Herold KC; Otten GR; Lancki DW; Gajewski T; Vogel SN; Fitch FW
    J Immunol; 1987 Dec; 139(12):3942-8. PubMed ID: 3121725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of cyclosporine to prevent in vivo T cell priming in man. Studies in allogeneic spleen transplantation.
    Gonwa TA; Goeken NE; Schulak JA; Nghiem DD; Corry RJ
    Transplantation; 1985 Sep; 40(3):299-304. PubMed ID: 3898494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
    Nabors GS; Tarleton RL
    J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 2, interferon, and lymphotoxin in renal transplant recipients.
    McKenna RM; Rush DN; Bakkestad-Legare P; Jeffery JR
    Transplantation; 1988 Jan; 45(1):76-81. PubMed ID: 3122387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of staphylococcal enterotoxin A-induced lymphoproliferation and interleukin 2 production as indicators of immunotoxicity.
    Reid LL; Hastings KL; Gandolfi AJ; Van Ert M
    Drug Chem Toxicol; 1994; 17(1):1-14. PubMed ID: 8168430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cimetidine or ranitidine in renal transplant patients receiving cyclosporine.
    Barri YM; Ramos EL; Balagtas RS; Peterson JC; Karlix JL
    Clin Transplant; 1996 Feb; 10(1 Pt 1):34-8. PubMed ID: 8652895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel sulphate conjugate of cyclosporine occurring in high concentrations in vivo.
    Johansson A; Henricsson S; Möller E
    Transplantation; 1990 Mar; 49(3):619-22. PubMed ID: 2316020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 1 stimulates proliferation of a nontransformed T lymphocyte line in the absence of a co-mitogen.
    Lacey DL; Chappel JC; Teitelbaum SL
    J Immunol; 1987 Oct; 139(8):2649-55. PubMed ID: 2958556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
    Kaplan JM; Badger AM; Ruggieri EV; Olivera DL; Newman-Tarr T; Bugelski PJ
    J Clin Lab Immunol; 1991 Dec; 36(4):49-58. PubMed ID: 1668843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine leukemic cells inhibit IL 2 production by susceptible syngeneic splenocytes.
    Jenski LJ; Ledford T
    J Immunol; 1985 Nov; 135(5):3178-83. PubMed ID: 2931479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes.
    Harris DT; Kozumbo WJ; Cerutti PA; Cerottini JC
    Cell Immunol; 1987 Oct; 109(1):104-14. PubMed ID: 3115596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.